Healthcare / Health Information ServicesLSE
$1568.00
+22.00 (+1.42%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $24.9M · quality 67.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
49/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$537M
P/E
33.4x
↑EV/EBITDA
1020.0x
↑ROE
3.6%
↑Gross Margin
85.7%
↑Debt/Equity
0.12
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
+35.8%
FCF CAGR
+23.5%
FCF margin
13.2%
FCF / Net income
2.13x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $189.3M · net income $11.7M · FCF $24.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $189.3M | $189.3M | $174.0M | $165.5M | $75.6M |
| Net Income | $11.7M | $11.7M | $9.2M | $9.4M | $12.9M |
| EBITDA | $54.3M | $54.3M | $51.6M | $47.5M | $18.5M |
| EPS | 0.33 | 0.33 | 0.26 | 0.27 | — |
| Gross Margin | 85.7% | 85.7% | 85.3% | 86.0% | 92.9% |
| Operating Margin | 11.0% | 11.0% | 9.9% | 11.2% | 26.2% |
| Net Margin | 6.2% | 6.2% | 5.3% | 5.7% | 17.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.12 | 0.12 | 0.26 | 0.35 | 0.01 |
| Current Ratio | 0.77 | 0.77 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $24.9M | $24.9M | $83.2M | $12.9M | $13.2M |
| Returns | |||||
| ROE | 3.6% | 3.6% | 2.8% | 2.8% | 5.0% |
| Valuation | |||||
| P/E | 33.36 | 33.36 | 5517.24 | 6226.42 | — |
| EV/EBITDA | 1019.97 | 1019.97 | 988.97 | 1232.86 | 3917.38 |
| P/B | 168.41 | 168.41 | 155.64 | 175.78 | 279.09 |
| Growth & Yield | |||||
| Revenue Growth | 8.8% | 8.8% | 5.1% | 119.0% | — |
| EPS Growth | 27.2% | 27.2% | -1.5% | — | — |
| Dividend Yield | 2.2% | 2.2% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
648.3%
EPS terminal req.
$139.13
Spread vs growth
-621.1%
5Y implied EPS CAGR
247.5%
EPS terminal req.
$168.35
Spread vs growth
-220.3%
10Y implied EPS CAGR
95.5%
EPS terminal req.
$271.13
Spread vs growth
-68.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-22.1%
Start / end P/E
7931.0x → 4722.9x
EPS bridge
0.26 → 0.33
Residual
-11.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.